SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-21-000623
Filing Date
2021-09-01
Accepted
2021-09-01 16:20:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT #2) d090121a.htm SC 13D/A 28602
  Complete submission text file 0000899140-21-000623.txt   30208
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Subject) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89598 | Film No.: 211230265
SIC: 2834 Pharmaceutical Preparations

Mailing Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587
Business Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587 82-2-920-8184
DONG-A ST CO., LTD (Filed by) CIK: 0001799260 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D/A